Loading article...
The American Oncology Institute (AOI) in Hyderabad has announced the introduction of triple-fluorescence robotic surgery for esophageal cancer, integrating Indocyanine Green (ICG) fluorescence-guided navigation with robotic technology. This technique was recently demonstrated during a robotic oesophagectomy performed on a 54-year-old patient from the United States.
The patient had been diagnosed with a 1.5 cm adenocarcinoma located at the gastroesophageal junction (GEJ) and underwent successful surgery using the 'Triple ICG Strategy', which provides real-time visualisation of tumours, blood supply, and critical anatomical structures during robotic surgery.
According to Senior Consultant Dr. Jagdishwar Goud, the integration of ICG fluorescence with robotic surgery enhances safety and oncological outcomes by providing objective, image-guided precision.
The hospital will continue to utilize this advanced technique to improve patient outcomes, with further details on its implementation and results expected in the coming weeks. The medical community is awaiting more information on the success of this new technique.